Temasek Life Sciences Private Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Temasek Life Sciences Private Ltd
CIK #0001379349
CIK Period
0001379349
Sector Form 13F Holdings Value ($B)
BlackRock Inc 5.1
Visa Inc 2.0
Nvidia Corp 1.6
Mastercard Inc 1.6
Alphabet Inc 1.4
Broadcom Inc 1.1
Amazon Com Inc 1.0
Microsoft Corp 1.0
Thermo Fisher Scientific Inc 0.6
McGraw-Hill Companies Inc 0.6
GE Vernova Inc 0.6
Doordash Inc 0.5
Pinduoduo Inc 0.5
Intapp Inc 0.4
Roblox Corp 0.4
Sea Ltd 0.4
TPG Inc 0.4
KKR & Co LP 0.3
HDFC Bank Ltd 0.3
Teck Resources Ltd 0.3
Ermenegildo Zegna NV 0.3
Airbnb Inc 0.3
GE Healthcare Technologies Inc 0.3
Apollo Global Management Inc 0.3
BeiGene Ltd 0.3
Transdigm Group Inc 0.3
Linde PLC 0.2
Priceline Com Inc 0.2
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
13F-NT [0001379349]
3 [0001379349]
4 [0001379349]
Form 3/4/5 Subject 2011 - 2026
TLS Beta Pte Ltd
Temasek Life Sciences Private Ltd
Fullerton Management Pte Ltd
Akili Inc
Temasek Holdings Private Ltd
Elbrus Investments Pte Ltd
Pear Therapeutics Inc
Coherus Oncology Inc
V-Sciences Investments Pte Ltd
Vir Biotechnology Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Akili Inc AKLI
Earnout Shares · derivative
2024-07-02 Tender 1,172,697
Akili Inc AKLI
Common Stock, par value $0.0001
2024-07-02 Tender 10,336,425
Vir Biotechnology Inc VIR
Series A-1 Preferred Stock · derivative
2019-10-16 Conversion 3,333,333
Vir Biotechnology Inc VIR
Common Stock
2019-10-16 Buy 500,000 $20.00 10,000,000
Vir Biotechnology Inc VIR
Common Stock
2019-10-16 Conversion 3,333,333
Vir Biotechnology Inc VIR
Series B Preferred Stock · derivative
2019-10-16 Conversion 1,666,666
Vir Biotechnology Inc VIR
Common Stock
2019-10-16 Conversion 1,666,666
Guardant Health Inc GH
SERIES D PREFERRED STOCK · derivative
2018-10-09 Conversion 1,016,995
Guardant Health Inc GH
COMMON STOCK
2018-10-09 Conversion 596,012
Guardant Health Inc GH
COMMON STOCK
2018-10-09 Conversion 1,016,995
Guardant Health Inc GH
SERIES E PREFERRED STOCK · derivative
2018-10-09 Conversion 596,012
Q32 Bio Inc FIXX
Common Stock
2018-04-02 Conversion 989,612
Q32 Bio Inc FIXX
Common Stock
2018-04-02 Conversion 1,605,681
Q32 Bio Inc FIXX
Series A Preferred Stock · derivative
2018-04-02 Conversion 1,605,681
Q32 Bio Inc FIXX
Series B Preferred Stock · derivative
2018-04-02 Conversion 989,612
Q32 Bio Inc FIXX
Common Stock
2018-04-02 Buy 625,000 $16.00 10,000,000
Intellia Therapeutics Inc NTLA
Series B Preferred Stock · derivative
2016-05-11 Conversion 490,527 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2016-05-11 Buy 300,000 $18.00 5,400,000
Intellia Therapeutics Inc NTLA
Common Stock
2016-05-11 Conversion 490,527
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com